The DOI matches its Crossref record; 321 of the 321 references it cites were found in a registry or an index.
Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–321 of 321
Success Stories of Computer‐Aided Design
Kubinyi, H. (2006) · Wiley eBooks · doi:10.1002/0470037237.ch16 · Cited by 93
Alhadrami, H. A., Hamed, A. A., Hassan, H. M., Belbahri, L., Rateb, M. E., & Sayed, A. M. (2020) · Antibiotics · doi:10.3390/antibiotics9090562 · Cited by 93
Practical Considerations in Virtual Screening and Molecular Docking
Berry, M. J., Fielding, B. C., & Gamieldien, J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802508-6.00027-2 · Cited by 92
Function-specific virtual screening for GPCR ligands using a combined scoring method
Kooistra, A. J., Vischer, H. F., McNaught-Flores, D. A., Leurs, R., de Esch, I. J. P., & de Graaf, C. (2016) · Scientific Reports · doi:10.1038/srep28288 · Cited by 92
QM/MM Approaches in Medicinal Chemistry Research
Menikarachchi, L. C., & Gascón, J. A. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790232297 · Cited by 91
Carlsson, J., Boukharta, L., & Åqvist, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7012198 · Cited by 91
Molecular dynamics analysis to evaluate docking pose prediction
Sakano, T., Mahamood, M. I., Yamashita, T., & Fujitani, H. (2016) · Biophysics and Physicobiology · doi:10.2142/biophysico.13.0_181 · Cited by 91
Enzymatic Catalysis: The Emerging Role of Conceptual Density Functional Theory
Roos, G., Geerlings, P., & Messens, J. (2009) · The Journal of Physical Chemistry B · doi:10.1021/jp9034584 · Cited by 90
Biopharmaceutics Applications in Drug Development
Krishna, R., & Yu, L. X. (2007) · Springer eBooks · doi:10.1007/978-0-387-72379-2 · Cited by 90
Nogara, P. A., Saraiva, R. D. A., Caeran Bueno, D., Lissner, L. J., Lenz Dalla Corte, C., Braga, M. M., Rosemberg, D. B., & Rocha, J. B. T. (2015) · BioMed Research International · doi:10.1155/2015/870389 · Cited by 89
The future of the protein data bank
Berman, H. M., Kleywegt, G. J., Nakamura, H., & Markley, J. L. (2012) · Biopolymers · doi:10.1002/bip.22132 · Cited by 88
Structure-based Virtual Screening Approaches in Kinase-directed Drug Discovery
Bajusz, D., Ferenczy, G. G., & Keserű, G. M. (2017) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026617666170224121313 · Cited by 88
MM-ISMSA: An Ultrafast and Accurate Scoring Function for Protein–Protein Docking
Klett, J., Núñez-Salgado, A., Santos, H. G. D., Cortés-Cabrera, Á., Perona, A., Gil‐Redondo, R., Abia, D., Gago, F., & Morreale, A. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300497z · Cited by 87
Gupta, S. K., Singh, V. K., Varadwaj, P. K., Chakravartty, N., Katta, A. V. S. K. M., Lekkala, S. P., Thomas, G., Narasimhan, S., Reddy, A. R., & Lachagari, V. B. R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1837679 · Cited by 87
The Future of Virtual Compound Screening
Heikamp, K., & Bajorath, J. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12054 · Cited by 86
Chemoinformatics-based enumeration of chemical libraries: a tutorial
Saldívar‐González, F. I., Huerta-García, C. S., & Medina‐Franco, J. L. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00466-z · Cited by 85
Ultrafast shape recognition: Evaluating a new ligand-based virtual screening technology
Ballester, P. J., Finn, P. W., & Richards, W. G. (2009) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2009.01.001 · Cited by 83
Practical Model Selection for Prospective Virtual Screening
Liu, S., Alnammi, M., Ericksen, S. S., Voter, A. F., Ananiev, G. E., Keck, J. L., Hoffmann, F. M., Wildman, S. A., & Gitter, A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00363 · Cited by 82
Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
Sayed, A. M., Alhadrami, H. A., EL-Gendy, A. O., Shamikh, Y. I., Belbahri, L., Hassan, H. M., Abdelmohsen, U. R., & Rateb, M. E. (2020) · Microorganisms · doi:10.3390/microorganisms8070970 · Cited by 81
Pharmacokinetic study with computational tools in the medicinal chemistry course
de Brito, M. A. (2011) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502011000400017 · Cited by 79
Practices in Molecular Docking and Structure-Based Virtual Screening
dos Santos, R. N., Ferreira, L. L. G., & Andricopulo, A. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7756-7_3 · Cited by 77
Alamri, M. A., Altharawi, A., Alabbas, A. B., Alossaimi, M. A., & Alqahtani, S. M. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.08.004 · Cited by 77
Computer-Aided Drug Design: An Innovative Tool for Modeling
Kore, P. P., Mutha, M. M., Antre, R. V., Oswal, R. J., & Kshirsagar, S. S. (2012) · Open Journal of Medicinal Chemistry · doi:10.4236/ojmc.2012.24017 · Cited by 74
Computational Drug Design Targeting Protein-Protein Interactions
Bienstock, R. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436449 · Cited by 70
Gupta, P. S. S., Bhat, H. R., Biswal, S., & Rana, M. K. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.114375 · Cited by 70
Homology Model-Based Virtual Screening for GPCR Ligands Using Docking and Target-Biased Scoring
Weil, T., & Renner, S. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci8000265 · Cited by 69
Virtual screening strategies in medicinal chemistry: the state of the art and current challenges.
Braga, R., Alves, V. M., Silva, A., Nascimento, M. N., Silva, F. C., Lião, L., & Andrade, C. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140929120749 · Cited by 69
Rutenber, E. E., & Stroud, R. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00139-6 · Cited by 67
The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
Kalliokoski, T., Salo, H. S., Lahtela-Kakkonen, M., & Poso, A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900364w · Cited by 66
New Trends in Virtual Screening
Walters, W. P., & Wang, R. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01009 · Cited by 64
Anti-COVID-19 terpenoid from marine sources: A docking, admet and molecular dynamics study
Sepay, N., Aishwarya, S., Halder, U. C., AlArifi, A. S., & Afzal, M. F. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129433 · Cited by 63
Manh, D. N., & Dudarev, S. L. (2014) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2014.11.097 · Cited by 61
(2009) · Wiley eBooks · doi:10.1002/9780470524961 · Cited by 60
Inverse Virtual Screening allows the discovery of the biological activity of natural compounds
Lauro, G., Masullo, M., Piacente, S., Riccio, R., & Bifulco, G. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.072 · Cited by 60
Jamkhande, P. G., Ghante, M. H., & Ajgunde, B. R. (2017) · Bulletin of Faculty of Pharmacy Cairo University · doi:10.1016/j.bfopcu.2017.10.001 · Cited by 59
Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
Alamri, M. A., Qamar, M. T. U., Mirza, M. U., Alqahtani, S. M., Froeyen, M., & Chen, L. (2020) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2020.08.012 · Cited by 59
Chemoinformatics: A view of the field and current trends in method development
Vogt, M., & Bajorath, J. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.030 · Cited by 58
Interactive molecular dynamics in virtual reality for accurate flexible protein-ligand docking
Deeks, H. M., Walters, R. K., Hare, S. R., O’Connor, M. B., Mulholland, A. J., & Glowacki, D. R. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228461 · Cited by 58
Application of computational methods for anticancer drug discovery, design, and optimization
Prada‐Gracia, D., Huerta‐Yépez, S., & Moreno‐Vargas, L. M. (2016) · Boletín Médico Del Hospital Infantil de México (English Edition) · doi:10.1016/j.bmhime.2017.11.040 · Cited by 58
NMR-Fragment Based Virtual Screening: A Brief Overview
Singh, M., Tam, B., & Akabayov, B. (2018) · Molecules · doi:10.3390/molecules23020233 · Cited by 57
Dhankhar, P., Dalal, V., Singh, V., Tomar, S., & Kumar, P. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1852968 · Cited by 56
Nurisso, A., Bravo, J., Carrupt, P., & Daina, A. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200515g · Cited by 55
An automated framework for NMR chemical shift calculations of small organic molecules
Yesiltepe, Y., Nuñez, J., Colby, S., Thomas, D., Borkum, M., Reardon, P. N., Washton, N., Metz, T., Teeguarden, J., Govind, N., et al. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0305-8 · Cited by 55
Jabir, N. R., Shakil, S., Tabrez, S. S. M., Khan, M. S., Rehman, M. T., & Ahmed, A. B. A. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1784796 · Cited by 54
Sohraby, F., Bagheri, M., & Aryapour, H. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_2 · Cited by 53
Ambrisentan: a review of its use in pulmonary arterial hypertension
Rivera‐Lebron, B. N., & Risbano, M. G. (2017) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465817696040 · Cited by 51
Dobeš, P., Fanfrlík, J., Řezáč, J., Otyepka, M., & Hobza, P. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9413-5 · Cited by 49
Zhang, S., Dou, Y., Zhou, J., Pu, M., Yan, H. J., Wei, M., Evans, D. G., & Duan, X. (2016) · ChemPhysChem · doi:10.1002/cphc.201600354 · Cited by 48
Adam, M. (2005) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2005.07.003 · Cited by 45
Efficient iterative virtual screening with Apache Spark and conformal prediction
Ahmed, L., Georgiev, V., Capuccini, M., Salman Zubair, T. O. O. R., Schaal, W., Laure, E., & Spjuth, O. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0265-z · Cited by 45
Afifi, K., & Al‐Sadek, A. F. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13206 · Cited by 45
Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators
Pérez-Regidor, L., Zarioh, M., Ortega, L. G., & Martín‐Santamaría, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091508 · Cited by 44
Protein structure and computational drug discovery
Nero, T. L., Parker, M. W., & Morton, C. J. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180202 · Cited by 42
Drug repurposing a reality: from computers to the clinic
Issa, N. T., Kruger, J., Byers, S. W., & Dakshanamurthy, S. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.79 · Cited by 41
Sabe, V. T., Tolufashe, G. F., Ibeji, C. U., Maseko, S. B., Govender, T., Maguire, G. E. M., Lamichhane, G., Honarparvar, B., & Kruger, H. G. (2019) · Journal of Molecular Modeling · doi:10.1007/s00894-019-4196-z · Cited by 41
Self-citationUnraveling pedestrian mobility on a road network using ICTs data during great tourist events
Mizzi, C., Fabbri, A., Rambaldi, S., Bertini, F., Curti, N., Sinigardi, S., Luzi, R., Venturi, G., Davide, M., Muratore, G., et al. (2018) · EPJ Data Science · doi:10.1140/epjds/s13688-018-0168-2 · Cited by 40
Computational Methods for Drug Repurposing
(2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3 · Cited by 40
Manish, M., Mishra, S., Anand, A., & Subbarao, N. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106125 · Cited by 40
Moult, J. (2006) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2005.1810 · Cited by 38
Hengphasatporn, K., Garon, A., Wolschann, P., Langer, T., Shigeta, Y., Huynh, T. N. T., Chavasiri, W., Saelee, T., Boonyasuppayakorn, S., & Rungrotmongkol, T. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm88010002 · Cited by 38
Machine Learning in Drug Discovery
Hochreiter, S., Klambauer, G., & Rarey, M. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00478 · Cited by 36
Anti-HIV Drug Development Through Computational Methods
Gu, W.-G., Zhang, X., & Yuan, J. F. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9604-9 · Cited by 36
Knowledge-Based Scoring Functions in Drug Design: 2. Can the Knowledge Base Be Enriched?
Shen, Q., Xiong, B., Zheng, M., Luo, X., Luo, C., Liu, X., Du, Y., Li, J., Zhu, W., Shen, J., et al. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100343j · Cited by 35
Khalid, S., Zahid, M., Ali, H., Kim, Y. S., & Khan, S. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0472-6 · Cited by 35
Yoshimori, A., Kawasaki, E., Kanai, C., & Tasaka, T. (2020) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00625 · Cited by 35
Computational screening for potential drug candidates against the SARS-CoV-2 main protease
Andrade, B. S., Ghosh, P., Barh, D., Tiwari, S., Silva, R. J. S., Soares, W. R. D. A., Melo, T. S., Freitas, A. S., González-Grande, P., Palmeira, L. S., et al. (2020) · F1000Research · doi:10.12688/f1000research.23829.2 · Cited by 34
Impact in interdisciplinary and cross‐sector research: Opportunities and challenges
Gooch, D., Vasalou, A., & Benton, L. (2016) · Journal of the Association for Information Science and Technology · doi:10.1002/asi.23658 · Cited by 33
Computational Prediction of Potential Inhibitors of the Main Protease of SARS-CoV-2
Abel, R., Paredes-Ramos, M., Chen, Q., Pérez‐Sánchez, H., Coluzzi, F., Rocco, M., Marchetti, P., Mura, C., Simmaco, M., Bourne, P. E., et al. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.590263 · Cited by 33
Drug discovery and molecular modeling using artificial intelligence
Bohr, H. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818438-7.00003-4 · Cited by 31
Kumar, P., Dalal, V., Kokane, A. D., Singh, S., Lonare, S., Kaur, H., GHOSH, D. K., Kumar, P., & Sharma, A. K. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.250 · Cited by 30
Coimbra, J. R. M., Baptista, S. J., Dinis, T. C. P., Silva, M. M., Moreira, P. I., Santos, A. E., & Salvador, J. A. R. (2020) · Biomolecules · doi:10.3390/biom10040535 · Cited by 30
Santibáñez‐Morán, M. G., López‐López, E., Prieto-Martínez, F. D., Sánchez‐Cruz, N., & Medina‐Franco, J. L. (2020) · RSC Advances · doi:10.1039/d0ra04922k · Cited by 30
Computer-aided drug design against spike glycoprotein of SARS-CoV-2 to aid COVID-19 treatment
Shehroz, M., Zaheer, T., & Hussain, T. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05278 · Cited by 30
Accurate Detection of Protein:Ligand Binding Sites Using Molecular Dynamics Simulations
Bhinge, A., Chakrabarti, P., Uthanumallian, K., Pahuja, K. B., Chakraborty, K., & Varadarajan, R. (2004) · Structure · doi:10.1016/j.str.2004.09.005 · Cited by 29
Singh, N. P., Sun, H., Chaudhury, S., AbdulHameed, M. D. M., Wallqvist, A., & Tawa, G. J. (2012) · Journal of Cheminformatics · doi:10.1186/1758-2946-4-4 · Cited by 29
Ghamari, N., Zarei, O., Reiner‐Link, D., Dastmalchi, S., Stark, H., & Hamzeh‐Mivehroud, M. (2018) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13471 · Cited by 29
Beura, S., & Chetti, P. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.128271 · Cited by 29
Molecular Dynamics as a Tool for Virtual Ligand Screening
Menchon, G., Maveyraud, L., & Czaplicki, G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7756-7_9 · Cited by 28
Barage, S. H., Karthic, A., Bavi, R., Desai, N. S., Kumar, R., Kumar, V., & Lee, K. W. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1841026 · Cited by 28
The preclinical discovery and development of dolutegravir for the treatment of HIV
Bailly, F., & Cotelle, P. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1064896 · Cited by 26
Convolutional architectures for virtual screening
Mendolia, I., Contino, S., Perricone, U., Ardizzone, E., & Pirrone, R. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03645-9 · Cited by 24
Feature analysis of multidisciplinary scientific collaboration patterns based on PNAS
Xie, Z., Li, M., Li, J., Duan, X., & Ouyang, Z. (2018) · EPJ Data Science · doi:10.1140/epjds/s13688-018-0134-z · Cited by 23
Discovery of Targeted Covalent Natural Products against PLK1 by Herb-Based Screening
Liang, H., Liu, H., Kuang, Y., Chen, L., Ye, M., & Lai, L. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00074 · Cited by 23
Impact of Computational Structure-based Methods on Drug Discovery
Reynolds, C. H. (2014) · Current Pharmaceutical Design · doi:10.2174/138161282020140528105532 · Cited by 22
New Trends in Virtual Screening
Walters, W. P., & Wang, R. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00728 · Cited by 22
From Computers to Bedside: Computational Chemistry Contributing to FDA Approval
Athanasiou, C., & Cournia, Z. (2018) · Methods and principles in medicinal chemistry · doi:10.1002/9783527806836.ch7 · Cited by 21
Baskin, I. I., & Varnek, A. A. (2009) · ChemInform · doi:10.1002/chin.200920272 · Cited by 21
Shawon, J., Khan, A. M., Shahriar, I., & Halim, M. A. (2021) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2021.100528 · Cited by 21
Preclinical discovery and development of maraviroc for the treatment of HIV
Veljković, N., Vučićević, J., Tassini, S., Glišić, S., Veljković, V., & Radi, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1041497 · Cited by 20
Malik, V., Dhanjal, J. K., Kumari, A., Radhakrishnan, N., Singh, K., & Sundar, D. (2017) · Methods · doi:10.1016/j.ymeth.2017.08.010 · Cited by 20
Small-Molecule Inhibitors of Protein–Protein Interactions
Liu, Z., Chen, H., Wold, E. A., & Zhou, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12326-1 · Cited by 19
Raj, R., Agarwal, N., Raghavan, S. S., Chakraborti, T., Poluri, K. M., & Kumar, D. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.039 · Cited by 19
Xiao, S., Wei, L., Hong, Z., Rao, L., Ren, Y., Wan, J., & Feng, L. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.023 · Cited by 18
Flores-Rojas, E., Cruz‐Martínez, H., Rojas-Chávez, H., Tellez-Cruz, M. M., Reyes-Rodríguez, J. L., Cabañas-Moreno, J. G., Calaminici, P., & Solorza‐Feria, O. (2018) · Electrocatalysis · doi:10.1007/s12678-018-0474-2 · Cited by 17
Pasqualetto, G., Schepelmann, M., Varricchio, C., Pileggi, E., Khogali, C., Morgan, S. R., Boostrom, I., Rôżanowska, M., Brancale, A., Ferla, S., et al. (2020) · Molecules · doi:10.3390/molecules25214904 · Cited by 17
Amikacin Inhibits miR-497 Maturation and Exerts Post-ischemic Neuroprotection
Sugunan, S., Fayaz, S. M., Charles, K. D., Suvanish, V. K., Kapfhammer, J. P., & Rajanikant, G. K. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9940-0 · Cited by 16
Sun, C. L., Christensen, J. G., & McMahon, G. (2009) · Wiley eBooks · doi:10.1002/9780470524961.ch1 · Cited by 15
A primer on natural product-based virtual screening
Koulouridi, E., Valli, M., Ntie‐Kang, F., & Bolzani, V. D. S. (2019) · Physical Sciences Reviews · doi:10.1515/psr-2018-0105 · Cited by 15
LigMate: A Multifeature Integration Algorithm for Ligand-Similarity-Based Virtual Screening
Grimm, M., Liu, Y., Yang, X., Bu, C., Xiao, Z. J., & Cao, Y. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b01210 · Cited by 15
4.05 – Ligand-Based Approaches: Core Molecular Modeling
Leach, A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00246-7 · Cited by 14
In silico screening and identification of potential GSK3β inhibitors
Daggupati, T., Pamanji, R., & Yeguvapalli, S. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1478854 · Cited by 14
GM-DockZn: a geometry matching-based docking algorithm for zinc proteins
Wang, K., Lyu, N., Diao, H., Jin, S., Zeng, T., Zhou, Y., & Wu, R. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa292 · Cited by 14
Vásquez, A. F., Reyes, A., Duitama, J., & Barrios, A. F. G. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1763839 · Cited by 13
Virtual Screening - models, methods and software systems
Lazarova, M. K. (2008) · Cited by 12
Computational Drug Discovery and Design
Gore, M., & Jagtap, U. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7756-7 · Cited by 11
Collection and preparation of molecular databases for virtual screening
Saxena, S. K., & Prathipati, P. (2006) · SAR and QSAR in environmental research · doi:10.1080/10629360600884462 · Cited by 10
The Discovery of Dacomitinib, a Potent Irreversible EGFR Inhibitor
Reed, J. E., & Smaill, J. B. (2016) · ACS symposium series · doi:10.1021/bk-2016-1239.ch008 · Cited by 10
Stahl, E. P., Nott, R., Koessel, K., Cance, W. G., & Marlowe, T. A. (2020) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13671 · Cited by 10
Learning RMSD to Improve Protein-Ligand Scoring and Pose SelectionPreprint
Aggarwal, R., & Koes, D. R. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11910870.v2 · Cited by 10
Ribonucleic Acid Viruses: Antivirals for Human Immunodeficiency Virus
Lyle, T. A. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00213-3 · Cited by 9
Rao, B. G., Murcko, M. A., Tebbe, M. J., & Kwong, A. D. (2015) · Wiley eBooks · doi:10.1002/9783527678433.ch10 · Cited by 9
Modeling Analysis of Potential Target of Dolastatin 16 by Computational Virtual Screening
Liang, T.-T., Zhao, Q., He, S., Mu, F., Deng, W., & Han, B. (2018) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00966 · Cited by 9
Fang, D. Q., Wu, W. J., Zhang, R., Zeng, G. H., & ZHENG, K. C. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01385.x · Cited by 8
Modern Drug Discovery and Development
Alexander, J. C., & Salazar, D. E. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373639-0.00025-x · Cited by 7
In Silico Screening of Compound Libraries Using a Consensus of Orthogonal Methodologies
Myrianthopoulos, V., Lambrinidis, G., & Mikros, E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8630-9_15 · Cited by 7
Rajapaksha, H., Perera, B. T., Meepage, J. N., Perera, W. P. R. T., & Dissanayake, C. (2020) · European Journal of Chemistry · doi:10.5155/eurjchem.11.4.351-363.2043 · Cited by 7
Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling
Bjij, I., Ramharack, P., Khan, S., Cherqaoui, D., & Soliman, M. E. S. (2019) · Molecules · doi:10.3390/molecules24173125 · Cited by 6
Licence Profile: Apache License, Version 2.0
Sinclair, A. H. (2010) · International Free and Open Source Software Law Review · doi:10.5033/ifosslr.v2i2.42 · Cited by 6
Stability constants of Cu(II)-piroxicam complexes in solution: a DFT study
Ledesma‐Olvera, L. G., Agacino‐Valdés, E., & Gómez‐Balderas, R. (2016) · Theoretical Chemistry Accounts · doi:10.1007/s00214-016-1996-4 · Cited by 6
A Hybrid Virtual Screening Protocol Based on Binding Mode Similarity
Anighoro, A., & Bajorath, J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8630-9_9 · Cited by 5
A Multibody Atomic Statistical Potential for Predicting Enzyme-Inhibitor Binding Energy
Masso, M. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.11.2258 · Cited by 2
Cited by
Computational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery
Muhammed, M. T., & Aki-Yalcin, E. (2024) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220922103109 · Cited by 267
Benchmarking compound activity prediction for real-world drug discovery applications
(2024) · doi:10.1038/s42004-024-01204-4 · Cited by 34
Baselious, F., Robaa, D., & Sippl, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107700 · Cited by 20
Barraza, G. A., Castro-Guijarro, A. C., de la Fuente Hoffmann, V., Bolívar Ávila, S. J., Flamini, M. I., & Sanchez, A. M. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108988 · Cited by 9
Metadata
- Authors
- Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 224
- Pages
- 113705
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W3182055317
- Cited by
- 625
- References
- 321
- FWCI
- 50.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.